Showing results (61-70 of 116) with videos related to
Sort By:
Pageof 12
Blood Advances|October 1, 2021
Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patientsMike Dennis, Ian F Thomas, Cono Ariti, et al.Nature Reviews. Clinical Oncology|September 6, 2012
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approachJan J Cornelissen, Alois Gratwohl, Richard F Schlenk, et al.Blood|April 27, 2011
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemiaJudith C Marsh, Vikas Gupta, Ziyi Lim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow TransplantationKate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.Cancer Chemotherapy and Pharmacology|January 8, 2021
Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemiaDongwoo Kang, Elizabeth Ludwig, David Jaworowicz, et al.Blood|July 20, 2002
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemiaNorbert Schmitz, Meral Beksac, Dirk Hasenclever, et al.BMC Cancer|November 15, 2022
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trialRichard Dillon, Shanna Maycock, Aimee Jackson, et al.Journal of Clinical Pharmacology|June 30, 2020
Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid LeukemiaDongwoo Kang, Elizabeth Ludwig, David Jaworowicz, et al.British Journal of Haematology|July 17, 2009
Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survivalTheo de Witte, Ronald Brand, Anja van Biezen, et al.Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.Pageof 12